"United States represents the largest market for human vaccines with
sales estimated at US$6.9 billion for 2007. Within Europe, France,
Germany, and United Kingdom together account for more than 3/4th of
the market. In Japan, Pediatric prophylactic vaccines sales are likely
to grow at a compounded annual rate of 9.9% over the period 2005-2010.
Human vaccines market in Asia-Pacific is projected to reach US$1.3
billion by the year 2010. Most multinational companies engaged in
vaccine production are based in the US and Europe.....Pediatric
combination vaccines, another new entrant in the vaccines market are
forecast to fuel growth in the coming years. The market is expected to
witness new levels with adoption of novel vaccine delivery mechanisms
such as edible, oral, and mucosal. Also critical to market success is
the need for using improved adjuvants in vaccines for optimal
immunogenicity.....Dominant players in the market comprise leading
pharmaceutical companies including Sanofi-Aventis, GlaxoSmithKline,
Wyeth, and Merck. These companies together command about 80% share of
the global human vaccines market." - Global Industry Analysts, Inc.

Barbara Loe Fisher Commentary:

If anyone doubts why drug companies making and selling vaccines are
lobbying so hard to convince California legislators to pass a
precedent-setting law that would automatically mandate every new
vaccine the CDC recommends for "universal use" by all children, the
recent market analysis by Global Industry Analysts gives the answer:
forcing vaccine use is a multi-billion dollar business. The U.S. is
the largest market for human vaccines: vaccine manufacturers will rake
in $6.9B in 2007. Much of the profit is guaranteed because the
lobbying alliance between drug companies, public health officials and
pediatricians that has formed during the past quarter century has
worked hard to convince politicians to mandate the use of more
vaccines by US citizens than are used by any other
Source NVIC7/19/07